If the Russia/Ukraine-related supply and demand shocks prove globally significant in 2022, the Federal Reserve, European Central Bank, Bank of Canada, and Bank of Japan will intervene in a coordinated fashion to provide market liquidity, cushioning most of the global economy from the worst economic consequences of the sanctions on Russia.
“if these shocks are really, really, really meaningful globally, I think you're going to see the Federal Reserve and the ECB and the Bank of Canada and the Bank of Japan step in, in a very coordinated way to provide liquidity to these markets. And I think what that has the byproduct of doing is blunting the economic consequences to everybody but the person who is sanctioned.”
View on YouTube
Explanation
Major central banks did not coordinate to provide liquidity in response to the Russia sanctions shock; instead, the Fed and other central banks pursued aggressive monetary tightening in 2022.
As a result of the spike in energy prices associated with the Russia/Ukraine crisis, the U.S. (and likely broader developed-world) economy will enter a recessionary contraction, prompting governments/central banks to shift toward more accommodative policies (easier monetary or fiscal stance) within the subsequent 12–18 months (i.e., by late 2023).
“We will contract as an economy. The government will have to become more accommodating.”
View on YouTube
Explanation
No official US recession was declared in the 12-18 months following this prediction, and central banks pursued tightening rather than accommodative policy.
Following early March 2022, the United States and its allies will continue to add further rounds of economic sanctions on Russia beyond those already announced on Russian crude and other sectors; the sanctions regime will materially intensify over the ensuing months of 2022.
“And just to speak on this other point, we have only just begun. Meaning just today, as we started the pod, uh, Biden came out with an incremental new set of sanctions on Russian crude. So we're not at the even in the beginning. We're at the beginning of the beginning.”
View on YouTube
Explanation
The US and its allies continued to add multiple additional rounds of sanctions on Russia throughout the remainder of 2022.
Russia will not ultimately lose the war in Ukraine to any alternative intervention or opposing force on the ground; Russia will find a way to avoid outright military defeat in Ukraine because of its nuclear deterrent and overall military capability.
“any sort of assumption that leads to our belief that an alternative intervention or some other force can ultimately win against Russia? Uh, is is completely false because Russia has thousands of nuclear warheads... I wouldn't kind of take any of this stuff, um, that Russia is going to lose a war, uh, you know, a war on the ground in the Ukraine. I mean, at the end of the day, they've got the ultimate trump card.”
View on YouTube
Explanation
The war in Ukraine has continued for years without a clear Russian military defeat, though it also has not produced a clear Russian victory, leaving this prediction's central claim only partially resolved.
As a result of Western policy around the Ukraine crisis, Russia will be pushed into a long‑term, durable strategic alignment with China, reducing the likelihood of Russia re‑aligning with the West in the foreseeable future.
“it's, uh, it's a transition that's happening mainly because of China. So we're in, you know, it seems like what we're doing is pushing Russia irrevocably into into his arms.”
View on YouTube
Explanation
Russia's strategic alignment with China deepened substantially and durably in the years following the 2022 invasion.
In response to the economic impact of Russia sanctions and recession risks in 2022, Federal Reserve Chair Jerome Powell, the Biden administration, and allied governments will likely shift to a more accommodative stance, effectively resuming monetary expansion ("money printing") to support the economy while maintaining strong economic sanctions on Russia, with the goal of engineering a soft landing instead of a recession.
“I think there could be a real possibility that Powell becomes very accommodative. And, you know, he and Biden and the entire administration come together with Europe and everybody else and say, get the money printer back going, because we are we are going to stand the line on these economic sanctions and we're going to, you know, sort of soft land, the economy here because we think there's recessionary risks afoot.”
View on YouTube
Explanation
The Federal Reserve and Biden administration pursued aggressive monetary tightening rather than resuming money printing in response to 2022 sanctions and recession risk.
The combination of sanctions on Russia and associated commodity/financial shocks will cause materially harmful economic impacts on emerging markets in Asia and Africa, leading to a period of significant economic difficulty there lasting for an extended but unspecified period of time (at least many months to a few years after early 2022).
“what's going to be very, very difficult is the impact that this has on emerging markets in Southeast Asia, Asia, Africa could be really, really deleterious for some amount of time and sad.”
View on YouTube
Explanation
Emerging markets in Asia and Africa experienced significant economic difficulty, including debt and food crises, in the wake of the 2022 commodity and financial shocks.
Over the long run (on the order of years to a couple of decades after 2022), the per‑patient production cost of cell therapies such as CAR‑T can be reduced to below $5,000.
“I think that over the long run, we can get the cost of cell therapies below 5000 bucks.”
View on YouTube
Explanation
Cell therapy costs remain far above $5,000 per patient as of 2026; this is a long-run prediction that has not yet been tested over its full intended timeframe.
In the long run (over the next couple of decades), CAR‑T and related engineered T‑cell therapies will be successfully developed and used clinically not only for cancers but also to treat autoimmune diseases such as lupus and multiple sclerosis (e.g., by targeting B cells or Epstein–Barr virus), as well as other specific pathogens, in a targeted manner.
“down the road, we could use Car-T to destroy, um, lupus or to destroy antibodies, B cells that are producing antibodies that are fundamentally causing autoimmune conditions, including what we talked about a few weeks ago, multiple sclerosis. Given that we now have a strong belief that if you can get rid of the EBV, the Epstein-Barr virus, from your body, you can wipe that out. So so car T can, in the long run, be harnessed not just for cancer, but autoimmunity and potentially other pathogens in the body in a really targeted way.”
View on YouTube
Explanation
CAR-T and related engineered T-cell therapies have shown strong clinical results for autoimmune diseases including lupus in the years following this prediction.